文献リスト

1) Takano M, Yamamoto M, Xie Y, et al. Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy. Heart. 2007; 93: 1533-6

2) Takano M, Yamamoto M, Murakami M, et al. Lack of association between large angiographic late loss and low risk of in-stent thrombus. Circ Cardiovasc Intervent. 2008; 1: 20-7

3) Yamamoto M, Okamatsu K, Inami S, et al. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy. Am Heart J. 2009; 158: 99-104

4) Yamamoto M, Takano M, Okamatsu K, et al. Relationship between thin cap fibroatheroma identified by virtual histology and angioscopic yellow plaque in quantitative analysis with colorimetry. Circ J. 2009; 73: 497-502

5) Takano M, Mizuno K, Okamatsu K, et al. Mechanism and structural characteristics of vulnerable plaques: analysis by coronary angio-scopy and intravascular ultrasound. J Am Coll Cardiol. 2001; 38: 99-104

6) Takano M, Yamamoto M, Inami E, et al. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist？ J Am Coll Cardiol. 2008; 52: 968-9

7) Xie Y, Takano M, Murakami D, et al. Comparison of neointimal coverage by boptical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three mongths after implantation. Am J Cardiol. 2008; 102: 27-31

8) Takano M, Jan IK, Inami S, et al. In vivo comparison of optical coherence tomography and angioscopy for the evaluation of coronary plaque characteristics. Am J Cardiol. 2008: 101: 471-6

9) Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation. 2006; 113: 2335-62

10) Ehara S, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation. 2001; 103: 1955-60

11) Meisinger C, et al. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation. 2005; 112: 651-7

12) Holvoet P, et al. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998; 98: 1487-94

13) Tajika K, et al. Malondialdehyde-modified low density lipoprotein is a novel marker as instability of coronary plaque: Angioscopic analysis. J Am Coll Cardiol. 2006; 47: 183A

14) Kashiwagi M, Tanaka A, Kitabata H, et al. Relationship between coronary arterial remodeling, fibrous cap thickness and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome. Circ J. 2009; 73: 1291-5

15) Li QX, Fu QQ, Shi SW, et al. Relationship between plasma inflammatory markers and plaque fibrous cap thickness determined by intravascular optical coherence tomography. Heart. 2010; 96: 196-201

16) Hayashida K, et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation. 2005; 112: 812-8

17) Kume N, et al. Soluble lectine-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome - a pilot study -. Circ J. 2010; 74: 1399-404

18) Brennan ML, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med. 2003; 349: 1595-604

19) Blankenberg S, Rupprecht HJ, Poirier O, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003; 107: 1579-85

20) Kai H, Ikeda H, Yasukawa H, et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol. 1998; 32: 368-72

21) Momiyama Y, et al. High plasma levels of matrix metalloproteinase-8 in patients with unstable angina. Atherosclerosis. 2010; 209: 206-10

22) Fukuda D, Shimada K, Tanaka A, et al. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am J Cardiol. 2006; 97: 175-80

23) Park JP, et al. Relationship between multiple plasma biomarkers and vulnerable plaque determined by virtual histology intravascular ultrasound. Circ J. 2010; 74: 332-6

24) Heeschen C, et al. (CAPTURE Study Investigators) Pregnancy-associated plasma protein-A in patients with acute coronary syndrome: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol. 2005; 45: 229-37

25) Iversen KK, et al. Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome. Am J Cardiol. 2009; 104: 1466-71

26) Heeschen C, et al; CAPTURE Investigators. Prognostic value of placental growth factor in patients with acute chest pain. JAMA. 2004; 291: 435-41

27) Markovic M, et al. Utility of placental growth factor for prediction of 30-day adverse event in emergency department population with non-ST elevation acute coronary syndrome. Clin Lab. 2010; 56: 215-22

28) Morrow DA, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol. 2003; 41: 1264-72

29) Jernberg T, et al. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol. 2002; 40: 437-45

30) Ogawa A, et al. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome. Circ J. 2006; 70: 1372-8

31) Hong YJ, et al. Relationship between N-terminal pro-BNP and coronary plaque components in patients with acute coronary syndrome: virtual histology-intravascular ultrasound analysis. Coron Artery Dis. 2009; 20: 518-24

32) Thygesen K, et al. Universal definition of myocardial infarction. Eur Heart J. 2007; 28: 2525-38

33) Latini R, et al. Prognostic value of very low plasma concentration of troponin T in patients with stable chronic heart failure. Circulation. 2007; 116: 1242-9

34) Jeremias A, et al. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing perctaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Circulation. 2008; 118: 632-8

35) Omland T, et al. Distribution and determinants of very low levels of cardiac troponin T in patients with stable coronary artery disease: The PEACE trial (abstract). Eur Heart J. 2008; 29 (Abstract Supplement): 202

36) Laufer EM, et al. The extent of coronary atherosclerosis is associated with increasing circukating levels of high sensitive cardiac troponin T. Arterioscler Thromb Vasc Biol. 2010; 30: 1269-75

37) Uetani T, et al. The association between plaque characterization by CT angiography and post-procedural myocardial infarction in patients with elective stent implantation. JACC Cardiovasc Imaging. 2010; 3: 19-28

38) Hong YJ, et al. Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis. JACC Cardiovasc imaging. 2009; 2: 458-68

39) Aminian A, et al. Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction. Eur J Intern Med. 2009; 20: 527-32

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp